Cited by

• Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay.

  Park K, Choi MK, Jung HH, Do IG, Lee KH, Ahn T, Kil WH, Kim SW, Lee JE, Nam SJ, Kim DH, Ahn JS, Im YH, Park YH. Park K, et al. Oncotarget. 2015 Sep 15;6(27):24499-510. doi: 10.18632/oncotarget.4119. Oncotarget. 2015. PMID: 26009992 Free PMC article.
• The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment.

  Kim JY, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH, Park YH. Kim JY, et al. Sci Rep. 2016 Aug 22;6:31804. doi: 10.1038/srep31804. Sci Rep. 2016. PMID: 27545642 Free PMC article.
• Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients.

  Sanz-Álvarez M, Cristóbal I, Luque M, Santos A, Zazo S, Madoz-Gúrpide J, Caramés C, Chiang CM, García-Foncillas J, Eroles P, Albanell J, Rojo F. Sanz-Álvarez M, et al. Cancers (Basel). 2021 Mar 12;13(6):1246. doi: 10.3390/cancers13061246. Cancers (Basel). 2021. PMID: 33809005 Free PMC article.
• The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

  Linardou H, Kalogeras KT, Kronenwett R, Kouvatseas G, Wirtz RM, Zagouri F, Gogas H, Christodoulou C, Koutras AK, Samantas E, Pectasides D, Bafaloukos D, Fountzilas G. Linardou H, et al. Breast Cancer Res. 2012 Nov 12;14(6):R145. doi: 10.1186/bcr3354. Breast Cancer Res. 2012. PMID: 23146280 Free PMC article. Clinical Trial.
• TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up.

  Millar E, Browne L, Slapetova I, Shang F, Ren Y, Bradshaw R, Ann Brauer H, O'Toole S, Beretov J, Whan R, Graham PH. Millar E, et al. Cancers (Basel). 2020 Aug 21;12(9):2365. doi: 10.3390/cancers12092365. Cancers (Basel). 2020. PMID: 32825588 Free PMC article.